Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasoactive prophylaxis to improve cochlear and facial nerve function after vestibular schwannoma surgery
DRKS00000328Phase 3Completed
- Sponsor
- Martin Luther University Halle-Wittenberg Medical Faculty
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of nimodipine and hetastarch in acoustic neuroma (2 arms), sponsored by Martin Luther University Halle-Wittenberg Medical Faculty. Primary endpoints: Cochlear nerve function preservation and Facial nerve function preservation. Started Feb 2010; status: completed.
02
Drugs
nimodipinehetastarch
03
Conditions
acoustic neuroma
Beyond the preview
Go deeper on DRKS00000328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000328.